Taiwan Liposome Company, Ltd. (TLC) |
| 7 0 (0%) 04-24 15:47 |
| Open: | 7 |
| High: | 7.09 |
| Low: | 7 |
| Volume: | 12,421 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 39.47 |
| Resistance 1: | 38.64 |
| Pivot price: | 38.43 |
| Support 1: | 37.30 |
| Support 2: | 31.03 |
| 52w High: | 7.7 |
| 52w Low: | 4.07 |
| EPS | 2.550 |
| Book Value | 19.630 |
| PEG Ratio | 5.74 |
| Gross Profit | 3.775 |
| Profit Margin (%) | 40.16 |
| Operating Margin (%) | 52.87 |
| Return on Assets (ttm) | 2.6 |
| Return on Equity (ttm) | 11.3 |
Thu, 24 Apr 2025
TLC Stock Price, News & Analysis | Taiwan Liposome Company, Ltd.c - Stock Titan
Mon, 13 Jun 2022
TLC Announces TLC599 Agreement with Endo - Yahoo Finance
Mon, 13 Jun 2022
Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain - PR Newswire
Wed, 08 Sep 2021
TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares - Yahoo Finance
Mon, 05 Jul 2021
TLC Announces Details of Stock Swap Transactions - GlobeNewswire
Wed, 19 Aug 2020
Taiwan Liposome Company, Ltd.c (TLC) Stock News - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |